Cited 0 times in
포도막염에 의한 낭포황반부종에서 유리체내스테로이드주사
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이성철 | - |
dc.date.accessioned | 2015-07-14T17:11:02Z | - |
dc.date.available | 2015-07-14T17:11:02Z | - |
dc.date.issued | 2004 | - |
dc.identifier.issn | 0378-6471 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/112373 | - |
dc.description.abstract | Purpose: To investigate the results of intravitreal injection of triamcinolone acetonide (TA) for the treatment of chronic uveitic cystoid macular edema (CME). Methods: Six patients, 8 eyes with refractory uveitic CME were included in the study. Four milligrams of TA was injected into the vitreous cavity. The clinical outcome and complication were reviewed, retrospectively. Results: Ten intravitreal injections of TA were performed, and the mean follow-up duration was 10.4 months (6∼19 months). Foveal retinal thickness diminished and CME improved anatomically in 7 (88%) eyes. Visual acuity improved by 1.75 lines of the Snellen chart in 6 (75%) eyes, and the time to improvement varied from 1 week to 8 months. Inflammation decreased in all eyes and there was symptomatic improvement in 6 (75%) eyes. CME recurred in 3 (38%) eyes at 4 to 16 weeks and re-treatments were performed in 2 eyes. Intraocular pressure increased in 3 eyes and one eye needed additional filtration surgery. Cataract worsened in one eye. Conclusions: Intravitreal triamcinolone injection effectively induced anatomic and symptomatic resolution, and decreased inflammation in uveitic CME patients. Nevertheless, the visual improvement was modest, and consideration for recurrence and complication is necessary. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1487~1495 | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | 포도막염에 의한 낭포황반부종에서 유리체내스테로이드주사 | - |
dc.title.alternative | Intravitreal Triamcinolone Injection for Uveitic Cystoid Macular Edema | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Ophthalmology (안과학) | - |
dc.contributor.googleauthor | 양훈 | - |
dc.contributor.googleauthor | 현종협 | - |
dc.contributor.googleauthor | 이성철 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.relation.journalcode | J01838 | - |
dc.identifier.eissn | 2092-9374 | - |
dc.subject.keyword | Cystoid macular edema | - |
dc.subject.keyword | Foveal retinal thickness | - |
dc.subject.keyword | Triamcinolone acetonide | - |
dc.subject.keyword | Uveitis | - |
dc.contributor.alternativeName | Lee, Sung Chul | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 45 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1487 | - |
dc.citation.endPage | 1495 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, Vol.45(9) : 1487-1495, 2004 | - |
dc.identifier.rimsid | 36274 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.